BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Psenicka MW, Smith BC, Tinkey RA, Williams JL. Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease? Front Cell Neurosci 2021;15:654284. [PMID: 34234647 DOI: 10.3389/fncel.2021.654284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Dean T, Ghaemmaghami J, Corso J, Gallo V. The cortical NG2-glia response to traumatic brain injury. Glia 2023;71:1164-75. [PMID: 36692058 DOI: 10.1002/glia.24342] [Reference Citation Analysis]
2 Mader MM, Napole A, Wu D, Shibuya Y, Scavetti A, Foltz A, Atkins M, Hahn O, Yoo Y, Danziger R, Tan C, Wyss-Coray T, Steinman L, Wernig M. Augmentation of a neuroprotective myeloid state by hematopoietic cell transplantation. bioRxiv 2023:2023. [PMID: 36945385 DOI: 10.1101/2023.03.10.532123] [Reference Citation Analysis]
3 Martella N, Pensabene D, Varone M, Colardo M, Petraroia M, Sergio W, La Rosa P, Moreno S, Segatto M. Bromodomain and Extra-Terminal Proteins in Brain Physiology and Pathology: BET-ing on Epigenetic Regulation. Biomedicines 2023;11:750. [DOI: 10.3390/biomedicines11030750] [Reference Citation Analysis]
4 Tavaf MJ, Soltanmohammadi A, Zargarani S, Yazdanpanah E, Sadighimoghaddam B, Yousefi B, Sameni HR, Haghmorad D. Berberine promotes immunological outcomes and decreases neuroinflammation in the experimental model of multiple sclerosis through the expansion of Treg and Th2 cells. Immun Inflamm Dis 2023;11:e766. [PMID: 36705421 DOI: 10.1002/iid3.766] [Reference Citation Analysis]
5 Serrano-Regal MP, Bayón-Cordero L, Chara Ventura JC, Ochoa-Bueno BI, Tepavcevic V, Matute C, Sánchez-Gómez MV. GABA(B) receptor agonist baclofen promotes central nervous system remyelination. Glia 2022;70:2426-40. [PMID: 35980256 DOI: 10.1002/glia.24262] [Reference Citation Analysis]
6 Hu X, Yu G, Liao X, Xiao L. Interactions Between Astrocytes and Oligodendroglia in Myelin Development and Related Brain Diseases. Neurosci Bull 2022. [DOI: 10.1007/s12264-022-00981-z] [Reference Citation Analysis]
7 Baldassarro VA, Stanzani A, Giardino L, Calzà L, Lorenzini L. Neuroprotection and neuroregeneration: roles for the white matter. Neural Regen Res 2022;17:2376-80. [PMID: 35535874 DOI: 10.4103/1673-5374.335834] [Reference Citation Analysis]
8 Ruzha Y, Ni J, Quan Z, Li H, Qing H. Role of Vitronectin and Its Receptors in Neuronal Function and Neurodegenerative Diseases. Int J Mol Sci 2022;23:12387. [PMID: 36293243 DOI: 10.3390/ijms232012387] [Reference Citation Analysis]
9 Dean T, Koffi AV, Goldstein E, Ghaemmaghami J, Gallo V. Endogenous Circadian Clock Machinery in Cortical NG2-Glia Regulates Cellular Proliferation. eNeuro 2022;9:ENEURO. [PMID: 36123116 DOI: 10.1523/ENEURO.0110-22.2022] [Reference Citation Analysis]
10 Smith BC, Tinkey RA, Shaw BC, Williams JL. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system. Immunol Rev 2022;311:39-49. [PMID: 35909222 DOI: 10.1111/imr.13121] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zveik O, Rechtman A, Haham N, Adini I, Canello T, Lavon I, Brill L, Vaknin-Dembinsky A. Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes. Int J Mol Sci 2022;23. [PMID: 35806122 DOI: 10.3390/ijms23137117] [Reference Citation Analysis]
12 Sobel RA, Albertelli M, Hinojoza JR, Eaton MJ, Grimes KV, Rubenstein E. Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple Sclerosis. J Neuropathol Exp Neurol 2022;81:414-33. [PMID: 35521963 DOI: 10.1093/jnen/nlac028] [Reference Citation Analysis]
13 Motyer A, Jackson S, Yang B, Harliwong I, Tian W, Shiu W, Shao Y, Wang B, Mclean C, Barnett M, Kilpatrick TJ, Leslie S, Rubio JP. The mutational landscape of single neurons and oligodendrocytes reveals evidence of inflammation-associated DNA damage in multiple sclerosis.. [DOI: 10.1101/2022.04.30.490132] [Reference Citation Analysis]
14 Schreiner TG, Romanescu C, Popescu BO. The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms. Biomolecules 2022;12:538. [DOI: 10.3390/biom12040538] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zveik O, Fainstein N, Rechtman A, Haham N, Ganz T, Lavon I, Brill L, Vaknin-Dembinsky A. Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells. Glia 2022. [PMID: 35266197 DOI: 10.1002/glia.24165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Perdaens O, van Pesch V. Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis. Front Neurol 2022;12:811518. [DOI: 10.3389/fneur.2021.811518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Liu L, Yang C, Candelario-Jalil E. Role of BET Proteins in Inflammation and CNS Diseases. Front Mol Biosci 2021;8:748449. [PMID: 34604312 DOI: 10.3389/fmolb.2021.748449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]